Additionally, anti‐CD47 antibody‐mediated phagocytosis of cancer cells has been shown to induce an antitumor T‐cell response via cross‐presentation of cancer cell antigens to the adaptive immune system,17 providing a second potential antitumor mechanism of action (MOA). The gene discussed is CD47; the disease is cancer.